JFJoseph Tr Fennelly

Joseph Tr Fennelly

*This is an algorithmically generated author record based on publicly available information.

Joseph Tr Fennelly has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Essex-Lopresti Injuries: A Systematic Review

    by Howard J. Stringer, Joseph T. Fennelly, James A. Kennedy, Daniel J. Brown

    Essex-Lopresti injuries (ELIs) are rare, and complex forearm injuries involving radial head fracture, interosseous membrane (IOM) rupture, and distal radioulnar joint (DRUJ) instability. We performed a systematic review to define diagnostic criteria, explore treatment strategies, and evaluate clinical outcomes. A PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses)-guided systematic review was conducted using EMBASE, EMCARE, and MEDLINE. Thirty-five studies encompassing 156 adult ELI cases were included, spanning both acute and chronic presentations. Data extraction included demographics, diagnostic methods, injury characteristics, management strategies, and outcomes. Studies were assessed for definitional consistency and treatment approaches. ELIs were often misdiagnosed, particularly in acute settings, contributing to a high rate of chronic instability. Most cases underwent surgical intervention, primarily targeting the radial head, with inconsistent attention to DRUJ and IOM repair. Radial head prosthesis, ulnar shortening osteotomy, and IOM reconstruction were more commonly applied in chronic cases. Conservative management was associated with poor outcomes unless applied to stable injury variants. Combined surgical interventions addressing multiple components of forearm stability yielded better outcomes, though variation in treatment approaches led to heterogeneity in results. Early and accurate diagnosis is critical to prevent chronic instability and functional loss in ELI. Surgical treatment should comprehensively address radial head integrity, DRUJ stability, and IOM function. There is no universally accepted management algorithm, and optimal treatment requires a patient-specific, multicomponent approach. Delayed diagnoses correlate with increased need for complex revisions and poorer outcomes. Systematic review of case reports and case series; Level IV evidence.

  • Fifteen-year survival analysis of an oxidised zirconium total knee arthroplasty

    by Joseph Tr Fennelly, Stylianos Papalexandris, Jill Pope, Joanne Yorke, John S Davidson, Alasdair Ja Santini


  • Open Access

    The Validation of Surgical Simulators: A Technical Report on Current Validation Terminology as a Reference for Future Research

    by Thomas Hughes, Joseph T. Fennelly, Rakesh Patel, Jonathan Baxter

    In recent years, surgical trainees have been exposed to a lower volume of operative procedures. In part, this is due to the reduction in working hours and further disruption by the coronavirus disease 2019 pandemic. Much has been done to develop the techniques of surgical skill training outside of the operating theatre. Simulation-based interventions must undergo a process of validation to assess their appropriateness and effectiveness for use in training. The terminology of validation within current literature, however, has not evolved in line with the education community, resulting in varying definitions for the same phrase across domains. This can result in confusion and misinterpretation among researchers and surgeons working within this domain. This technical report describes the “types of validity” definitions used in the traditional framework of surgical simulation literature and the contemporary, unitary framework of validity adopted by educationalist theorists. There is a clear overlap between the traditional “types of validity” and the contemporary, unitary framework. The divergence in the use of those definitions seems, at least partly, influenced by the context of the investigations being conducted. By utilising the contemporary definitions, authors may have struggled to provide the evidence required to justify the use of the multitude of surgical skill simulators developed in the recent past. This report has provided an overview of the current terminology within the validation frameworks and can be used as a reference for future surgical simulation research.


  • The acute management of ankle fractures (Augment) study: A prospective trainee led national collaborative audit of the Boast 12 guidelines

    by Joseph T Fennelly, Lysander J Gourbault, Tobias Stedman, Michael J Price, Alex E Ward, AUGMENT Collaborative


  • Open Access

    The ‘National Finals Revision Day’ Teaching Strategy: A Cost-Effective Way to Pass Medical School ‘Finals’ and Upskill Junior Doctors

    by Alexander Curtis, Gregory Neal-Smith, Joseph T. Fennelly, Richard Goodall, Edward Hayter, Charles Coughlan, Adam Miller, Daniel Huntley, Agnes Hamilton-Baillie, Henry M. Drysdale, et al.

    Courses to help medical students pass ‘Finals’ already exist but are typically expensive or can only be attended by a limited number of students. We describe the success of ‘The National Finals Revision Day' (NFRD) course, which we believe is sustainable and unique in terms of its combined scale and cost (£10 per person). The course was organised and taught by 12 junior doctors. In total, 300 students attended from 55% of UK medical schools. Attendees found the course both relevant (96.4%) and cost-effective (97%), whilst the 11 medical and surgical talks were of a high standard (90.1%). The organising committee felt confident to organise their own teaching course in the future with 100% having already run a course themselves since the NFRD course. The NFRD course was also used by 11/12 (91.7%) of the organising committee to achieve their Annual Review of Competency Progression (ARCP) and 12/12 (100%) of the organising committee to obtain jobs on training programmes in the UK. We provide guidance about how to organise similar large-scale events for those interested. Moving forward, the teaching course will be run at: (i) multiple times; (ii) multiple UK venues; (iii) run over two days to cover more medical and surgical topics; and (iv) include the option of attending via video link.

  • Open Access

    Peri‐operative administration of tranexamic acid in lower limb arthroplasty: a multicentre, prospective cohort study

    by T. D. Lloyd, G. Neal‐Smith, J. Fennelly, H. Claireaux, C. Bretherton, A. J. Carr, M. Murphy, B. J. Kendrick, A. J. R. Palmer, Collaborators

    Summary: In the UK , tranexamic acid is recommended for all surgical procedures where expected blood loss exceeds 500 ml. However, the optimal dose, route and timing of administration are not known. This study aimed to evaluate current practice of peri‐operative tranexamic acid administration. Patients undergoing primary total hip arthroplasty, total knee arthroplasty or unicompartmental knee arthroplasty during a 2‐week period were eligible for inclusion in this prospective study. The primary outcome was the proportion of patients receiving tranexamic acid in the peri‐operative period. Secondary outcomes included: dose, route and timing of tranexamic acid administration; prevalence of pre‐ and postoperative anaemia; estimated blood loss; and red blood cell transfusion rates. In total, we recruited 1701 patients from 56 NHS hospitals. Out of these, 1523 (89.5%) patients received tranexamic acid and of those, 1052 (69.1%) received a single dose of 1000 mg intravenously either pre‐ or intra‐operatively. Out of the 1701 patients, 571 (33.6%) and 1386 (81.5%) patients were anaemic (haemoglobin < 130 g.l −1 ) in the pre‐ and postoperative period, respectively. Mean ( SD ) estimated blood loss for all included patients was 792 (453) ml and 54 patients (3.1%) received a red blood cell transfusion postoperatively. The transfusion rate for patients with pre‐operative anaemia was 6.5%, compared with 1.5% in patients without anaemia. Current standard of care in the UK is to administer 1000 mg of tranexamic intravenously either pre‐ or intra‐operatively. Approximately one‐third of patients present for surgery with anaemia, although the overall red blood cell transfusion rate is low. These data provide useful comparators when assessing the efficacy of tranexamic acid and other patient blood management interventions in future studies.